Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily vs Alternate Day Plasma Exchange in Pediatric Wilson Disease
NCT06698991Not yet recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Reduction in New Wilson Index at 7 days. Planned start Nov 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06698991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06698991.